Spectral AI, Inc.
MDAI
NASDAQ·Healthcare·Medical - Specialties·Mkt cap $50.0M
$1.57
▲ +0.64%
P/E
-4.50
Mkt Cap
$50.0M
52-Wk Range
$1.18–$2.97
52-Week Range
$1.18 - $2.97
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 16.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary AI diagnostic technology with clinical validation
- First-mover advantage in objective wound assessment devices
- Regulatory pathway and FDA clearance positioning
- Strong intellectual property portfolio in medical AI
Bear Case
1 risk
- Average volatility.
Growth
Moderate growth ahead
Increasing adoption of AI in clinical diagnostics
Value
Deep value opportunity - significant discount to sector peers
Momentum
Weak
-16.9% over 3m
Quality
Strong
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying MDAI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 10, 2026
AUG 11, 2026
Reported EPS of -$0.13 vs -$0.14 consensus (+3.7% surprise). Revenue of $3.5M vs $4.2M expected (-15.4%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+3.7%
Revenue trend · last 8Q
—
—
+6%
-32%
-54%
-49%
-40%
-30%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$8.2M
$7.6M
$6.7M
$5.1M
$3.8M
$3.8M
$4.0M
$3.5M
Margins · last 8Q
Gross
31.6%
Operating
-174.6%
Profit
-118.5%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: BTIG · $4.00 · May 27, 2026
vs Industry
How MDAI stacks vs Medical - Specialties
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.